Pub. Date : 2013 Dec
PMID : 23888935
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | WHAT IS KNOWN AND OBJECTIVE: Ponatinib is a potent oral tyrosine kinase inhibitor with activity against BCR-ABL, the primary driver of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. | ponatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |